369 related articles for article (PubMed ID: 17962208)
21. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes.
Shirakata Y; Komurasaki T; Toyoda H; Hanakawa Y; Yamasaki K; Tokumaru S; Sayama K; Hashimoto K
J Biol Chem; 2000 Feb; 275(8):5748-53. PubMed ID: 10681561
[TBL] [Abstract][Full Text] [Related]
22. Decreased expression of epidermal growth factor receptor and mRNA of its ligands in Helicobacter pylori-infected gastric mucosa.
Schiemann U; Konturek JW; Osterhoff M; Assert R; Rembiasz K; Pfeiffer D; Schatz H; Domschke W; Pfeiffer A
Scand J Gastroenterol; 2001 Jan; 36(1):23-31. PubMed ID: 11218236
[TBL] [Abstract][Full Text] [Related]
23. Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and Tgfalpha mediated transactivation of the epidermal growth factor receptor.
Ogunwobi OO; Beales IL
Br J Biomed Sci; 2008; 65(3):121-7. PubMed ID: 18986098
[TBL] [Abstract][Full Text] [Related]
24. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family.
Barnard JA; Graves-Deal R; Pittelkow MR; DuBois R; Cook P; Ramsey GW; Bishop PR; Damstrup L; Coffey RJ
J Biol Chem; 1994 Sep; 269(36):22817-22. PubMed ID: 8077234
[TBL] [Abstract][Full Text] [Related]
25. Evolution of the predictive markers amphiregulin and epiregulin mRNAs during long-term cetuximab treatment of KRAS wild-type tumor cells.
Oliveras-Ferraros C; Massaguer Vall-Llovera A; Carrion Salip D; Vazquez-Martin A; Cufí S; Queralt B; Martin-Castillo B; Brunet J; de Llorens R; Menendez JA
Invest New Drugs; 2012 Apr; 30(2):846-52. PubMed ID: 21161326
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities.
Beerli RR; Hynes NE
J Biol Chem; 1996 Mar; 271(11):6071-6. PubMed ID: 8626392
[TBL] [Abstract][Full Text] [Related]
27. Expression of the epidermal growth factor system in human middle ear cholesteatoma.
Thorup MB; Munk M; Poulsen SS; Gaihede M; Nexo E; Sorensen BS; Ovesen T
Acta Otolaryngol; 2014 Feb; 134(2):124-34. PubMed ID: 24256036
[TBL] [Abstract][Full Text] [Related]
28. Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.
Qi CF; Liscia DS; Normanno N; Merlo G; Johnson GR; Gullick WJ; Ciardiello F; Saeki T; Brandt R; Kim N
Br J Cancer; 1994 May; 69(5):903-10. PubMed ID: 8180021
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells.
Miyazaki Y; Hiraoka S; Tsutsui S; Kitamura S; Shinomura Y; Matsuzawa Y
Gastroenterology; 2001 Jan; 120(1):108-16. PubMed ID: 11208719
[TBL] [Abstract][Full Text] [Related]
30. Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
Modjtahedi H; Komurasaki T; Toyoda H; Dean C
Int J Cancer; 1998 Jan; 75(2):310-6. PubMed ID: 9462724
[TBL] [Abstract][Full Text] [Related]
31. Co-expression of neuregulins 1, 2, 3 and 4 in human breast cancer.
Dunn M; Sinha P; Campbell R; Blackburn E; Levinson N; Rampaul R; Bates T; Humphreys S; Gullick WJ
J Pathol; 2004 Jun; 203(2):672-80. PubMed ID: 15141382
[TBL] [Abstract][Full Text] [Related]
32. Relationships between progesterone receptor isoforms and the HER/ErbB receptors and ligands network in 299 primary breast cancers.
Lindet C; Révillion F; Lhotellier V; Hornez L; Peyrat JP; Bonneterre J
Int J Biol Markers; 2012 Jul; 27(2):e111-7. PubMed ID: 22505232
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of EGFR ligands on endocytic sorting of the receptor.
Roepstorff K; Grandal MV; Henriksen L; Knudsen SL; Lerdrup M; Grøvdal L; Willumsen BM; van Deurs B
Traffic; 2009 Aug; 10(8):1115-27. PubMed ID: 19531065
[TBL] [Abstract][Full Text] [Related]
34. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
Zhang X; Diaz MR; Yee D
Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
[TBL] [Abstract][Full Text] [Related]
35. Binding specificities and affinities of egf domains for ErbB receptors.
Jones JT; Akita RW; Sliwkowski MX
FEBS Lett; 1999 Mar; 447(2-3):227-31. PubMed ID: 10214951
[TBL] [Abstract][Full Text] [Related]
36. Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer.
Yun S; Kwak Y; Nam SK; Seo AN; Oh HK; Kim DW; Kang SB; Lee HS
Cancer Res Treat; 2018 Oct; 50(4):1351-1361. PubMed ID: 29361822
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
38. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
Niikura H; Sasano H; Kaga K; Sato S; Yajima A
Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
[TBL] [Abstract][Full Text] [Related]
39. HER family receptor and ligand status in thymic carcinoma.
Weissferdt A; Lin H; Woods D; Tang X; Fujimoto J; Wistuba II; Moran CA
Lung Cancer; 2012 Sep; 77(3):515-21. PubMed ID: 22726920
[TBL] [Abstract][Full Text] [Related]
40. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
